VLS Income Statement - TTM - Vita Life Sciences Limited

Income Statement (TTM)

Vita Life Sciences Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	46	46	48	50	54	57	61	64	65	67	68	69	71	73	76	78	79	80	83	86
Change (%)		2.02	3.98	3.83	6.89	6.45	6.14	5.78	2.16	2.12	1.28	1.26	3.52	3.40	3.41	3.30	0.68	0.68	3.83	3.69
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	16	17	18	19	21	22	24	26	27	27	28	28	30	31	32	33	33	32	33	34
Change (%)		5.16	5.80	5.48	8.04	7.44	8.35	7.70	2.18	2.13	2.22	2.17	4.75	4.53	2.77	2.70	-0.77	-0.77	2.62	2.55
% of Revenue	35.92	37.02	37.67	38.27	38.68	39.04	39.85	40.58	40.58	40.59	40.96	41.33	41.82	42.28	42.02	41.77	41.17	40.58	40.11	39.66

Gross Operating Profit	29	29	30	31	33	35	36	38	39	40	40	40	41	42	44	46	46	47	49	52
Change (%)		0.26	2.92	2.84	6.18	5.82	4.72	4.51	2.16	2.11	0.63	0.63	2.66	2.59	3.88	3.74	1.72	1.69	4.66	4.45
% of Revenue	64.08	62.98	62.33	61.73	61.32	60.96	60.15	59.42	59.42	59.41	59.04	58.67	58.18	57.72	57.98	58.23	58.83	59.42	59.89	60.34

SG&A	22	21	22	22	23	24	25	26	27	29	29	29	30	30	32	33	34	35	37	39
Change (%)		-1.11	1.93	1.90	3.00	2.92	5.76	5.44	4.68	4.47	0.91	0.91	1.61	1.59	4.79	4.57	3.22	3.12	4.76	4.55
% of Revenue	47.44	45.99	45.08	44.24	42.63	41.22	41.07	40.94	41.94	42.91	42.75	42.60	41.82	41.08	41.63	42.15	43.21	44.26	44.66	45.02

R&D
Change (%)
% of Revenue

OpEx	38	39	40	42	44	46	49	53	54	56	57	58	60	62	64	66	67	68	70	73
Change (%)		1.57	3.58	3.45	5.27	5.00	7.16	6.68	3.29	3.19	1.41	1.39	3.30	3.19	3.88	3.74	1.14	1.13	3.81	3.67
% of Revenue	84.08	83.72	83.39	83.08	81.82	80.71	81.49	82.18	83.09	83.96	84.07	84.18	84.00	83.83	84.21	84.57	84.96	85.34	85.32	85.30

Operating Income	7	8	8	8	10	11	11	11	11	11	11	11	11	12	12	12	12	12	12	13
Change (%)		4.35	6.08	5.74	14.87	12.95	1.86	1.82	-3.04	-3.14	0.56	0.56	4.73	4.51	0.96	0.95	-1.85	-1.89	3.97	3.82
% of Revenue	15.92	16.28	16.61	16.92	18.18	19.29	18.51	17.82	16.91	16.04	15.93	15.82	16.00	16.17	15.79	15.43	15.04	14.66	14.68	14.70

Interest Expense	-0	-0	-0	-0	-0	-0	-0	-0	-0				-0	-0	-0	-0	-0	-0	-0	-0
Change (%)		7.56	-29.30	-41.44	3.77	3.64	-0.00	-0.00	-50.00					100.00	-0.00	-0.00	-11.67	-13.21	-0.00	-0.00
% of Revenue	-0.26	-0.28	-0.19	-0.11	-0.10	-0.10	-0.09	-0.09	-0.04				-0.04	-0.08	-0.08	-0.08	-0.07	-0.06	-0.06	-0.05

Net Income	6	6	6	7	8	8	8	8	8	7	7	7	8	9	9	9	9	9	9	9
Change (%)		9.21	5.11	4.86	11.72	10.49	-0.28	-0.28	-7.04	-7.57	2.37	2.32	11.19	10.06	1.82	1.78	-3.24	-3.53	2.99	2.91
% of Revenue	12.25	13.11	13.25	13.38	13.99	14.52	13.64	12.86	11.70	10.59	10.71	10.82	11.62	12.37	12.18	12.00	11.53	11.05	10.96	10.88

Source: Capital IQ

Vita Life Sciences Limited - Income Statement (TTM)

Income Statement (TTM)